(ANTIMEDIA) — One of the most reviled companies in the United States recently gave Americans yet another reason to distrust their power: A recent Goldman Sachs report reveals the company questioning whether or not curing chronic illness is compatible with a sustainable business model. In an internal report viewed by CNBC about the potential of the biotech industry and gene […]
Source